Core Viewpoint - The article highlights the proactive measures taken by Guilin Sanjin Pharmaceutical and local authorities to address intellectual property (IP) disputes faced by companies venturing into overseas markets, transforming challenges into opportunities for international competitiveness [1][3]. Group 1: Mechanisms for IP Protection - Guilin City has established six IP protection assistance stations to create a collaborative protection framework, allowing companies to receive quick and professional guidance on overseas IP issues [3]. - Since 2025, 175 IP disputes have been successfully resolved before litigation, with an average mediation period reduced to 53 days [3]. Group 2: Tailored Services for Companies - The Guilin market regulatory bureau has provided over 200 instances of IP "fast track" services to companies, with 35 new key enterprises added to the database since 2025 [4]. - For Guilin Sanjin Pharmaceutical, a combination protection strategy involving copyright and trade secrets was developed, resulting in the company holding over 200 registered trademarks [4]. - Guilin Sanjin's successful appeal against the misclassification of its PCT patent as "abnormal" preserved its valuable patent assets, leading to 29 PCT international patents and 94 domestic invention patent applications [4]. Group 3: Risk Prevention and Early Warning - Guilin has established a pre-warning mechanism for overseas IP disputes, providing 37 notifications on trademark registration and 140 on PCT patent expiration risks to key enterprises [6]. - During international exhibitions, expert teams are deployed to assist 94 participating companies with pre-exhibition IP dispute checks and risk notifications [6].

Core Viewpoint - Guilin Sanjin (002275.SZ) has confirmed that its products, Sanjin Pian and Xigua Shuang, are sold in various overseas markets, including Serbia in Eastern Europe, the United States and Canada in North America, Australia in Oceania, and most countries in Southeast Asia, with no sales currently in EU countries [1] Group 1 - The company has a diverse international market presence for its products [1] - Specific markets mentioned include Eastern Europe, North America, Oceania, and Southeast Asia [1] - There is currently no distribution of products in EU countries [1]

Group 1 - The company, Guilin Sanjin, has products sold in 17 countries, including markets in Eastern Europe, North America, Oceania, and Southeast Asia [2] - The company's products, Sanjin tablets and Watermelon Frost, are not currently sold in EU countries [2]

Core Viewpoint - Guilin Sanjin is expanding its overseas market presence for its products, Sanjin Pian and Xigua Shuang, leveraging brand reputation among overseas Chinese communities to penetrate local markets gradually [1] Market Expansion - The company has established sales in various overseas markets, including Serbia in Eastern Europe, the United States and Canada in North America, Australia in Oceania, and many countries in Southeast Asia [1] - The company acknowledges that market promotion and development require time to accumulate [1] Strategy - Guilin Sanjin plans to utilize its product reputation and brand advantages within overseas Chinese markets to facilitate growth in sales among local populations [1]

Core Viewpoint - The company, Guilin Sanjin, is actively expanding its overseas sales, particularly in markets such as Eastern Europe, North America, Oceania, and Southeast Asia, leveraging its brand reputation among overseas Chinese communities to penetrate local markets [1] Group 1 - The company has confirmed that its products, Sanjin tablets and Watermelon Frost, are sold in various overseas markets including Serbia, the United States, Canada, Australia, and many Southeast Asian countries [1] - The company aims to gradually increase sales by utilizing its brand advantages and reputation in overseas Chinese markets to penetrate local consumer markets [1]